400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / PI3K/Akt/mTOR / mTOR / Torkinib
CAS No.: 1092351-67-1
Synonyms: PP 242
PP 242 is the first selective and ATP competitive mTOR inhibitor with IC50 of 8 nM.
生物活性
靶点 | Bromodomain 4 Kd:1.7μM | mTOR IC50:8nM | p110δ IC50:100nM |
实验方案
技术信息
CAS号 | 1092351-67-1 | 储存条件 |
|
|||||||||||||
分子式 | C16H16N6O | 运输 | 蓝冰 | |||||||||||||
分子量 | 308.34 | 别名 | PP 242 | |||||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
3T3-L1 | 15 μM | Function Assay | 4 h | suppresses expression of the Egr1 protein | 25814662 |
786-O | 0.1/0.5 μM | Function Assay | 24 h | increases E-cadherin mRNA levels dose dependently | 23147251 |
786-O | 0-0.5 μM | Function Assay | 24 h | results in a dose dependent increase in E-cadherin protein expression | 23147251 |
8226 | 100-1000 nM | Function Assay | 30 min | activates ERK | 22556409 |
8226 | 0.5 μM | Function Assay | 30 min | induces activation of RAF and phosphorylation of MEK | 22556409 |
AGS | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
BaF3 | - | Growth Inhibition Assay | - | GI50=1.449 μM | 22223645 |
Bcap-37 | 50/200/500 nM | Function Assay | 30 min | dose-dependently (50–500 nM) suppresses phosphorylation of Akt | 22476852 |
Bcap-37 | 200 nM | Apoptosis Assay | 36 h | induces apoptosis | 22476852 |
Caco2 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
Caco-2 | - | Growth Inhibition Assay | - | IC50=0.22 μM | 23542178 |
COLO 201 | - | Growth Inhibition Assay | - | IC50=0.23 μM | 23542178 |
COLO 205 | - | Growth Inhibition Assay | - | IC50=0.24 μM | 23542178 |
Colo205 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
Colo320 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
Colo320 | 1 μM | Function Assay | 0-24 h | abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 | 23991179 |
DLD-1 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
DLD-1 | 1 μM | Function Assay | 0-24 h | abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 | 23991179 |
DLD-1 | 10/100/1000 nM | Function Assay | 6 h | inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein | 22401294 |
DND-1 | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
H116 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
HCT 116 | - | Growth Inhibition Assay | - | IC50=0.41 μM | 23542178 |
HCT 116 | - | Growth Inhibition Assay | - | IC50=0.6 μM | 22270257 |
HCT 15 | - | Growth Inhibition Assay | - | IC50=0.3 μM | 23542178 |
HCT15 | 0.5/2 μM | Function Assay | 4 h | prevents S6K1 phosphorylation of ribosomal protein S6 at Ser240/244 and mTORC2 phosphorylation of Akt at Ser473 | 21876130 |
HCT-15 | - | Growth Inhibition Assay | - | IC50=0.3 μM | 22270257 |
Hct-8 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
HMEC | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
HT1376 | - | Growth Inhibition Assay | - | IC50=1.88 ± 1.1 μM | 24054871 |
HT29 | 1 μM | Function Assay | 2 h | inhibits both mTORC1-mediated phosphorylation of S6K1 and mTORC2-mediated phosphorylation of Akt | 25762619 |
HT29 | 1 μM | Function Assay | 2 h | suppresses the basal or IGF-1-stimulated cell adhesion | 25762619 |
HT29 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
HT29 | 1 μM | Function Assay | 0-24 h | abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 | 23991179 |
HT-29 | - | Growth Inhibition Assay | - | IC50=0.23 μM | 23542178 |
HT-p21 | 50-1250 nM | Function Assay | 24 h | inhibits phosphorylation of S6 kinase (target of mTORC1) and its downstream target phospho-S6 | 26177051 |
HUVEC | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
Jurkat | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
Jurkat | 100/200/400 nM | Function Assay | 18 h | inhibits mTORC1-dependent S6 S235/236 phosphorylation | 22566604 |
Jurkat | 400nM | Growth Inhibition Assay | 24/48 h | synergize with 17-AAG to suppress cell proliferation | 22566604 |
KATO3 | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
KOPT-K1 | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
LS174T | 10/100/1000 nM | Function Assay | 6 h | inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein | 22401294 |
LS-174T | - | Growth Inhibition Assay | - | IC50=0.84 μM | 23542178 |
LS-513 | - | Growth Inhibition Assay | - | IC50=3.9 μM | 23542178 |
MCF-7 | 50/200/500 nM | Function Assay | 30 min | dose-dependently (50–500 nM) suppresses phosphorylation of Akt | 22476852 |
MCF-7 | 200 nM | Apoptosis Assay | 36 h | induces apoptosis | 22476852 |
MDA-MB-231 | 50/200/500 nM | Function Assay | 30 min | dose-dependently (50–500 nM) suppresses phosphorylation of Akt | 22476852 |
MDA-MB-231 | 200 nM | Apoptosis Assay | 36 h | induces apoptosis | 22476852 |
MG63 | 50-1000 nM | Function Assay | 0.5 h | dose dependently (50–1000 nM) inhibits phosphorylation of Akt | 24840134 |
MG63 | 100 nM | Apoptosis Assay | 36 h | promotes apoptosis | 24840134 |
MKN28 | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
MKN45 | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
MM1.S | 100-1000 nM | Function Assay | 30 min | activates ERK | 22556409 |
MM1.S | 0.5 μM | Function Assay | 30 min | induces activation of RAF and phosphorylation of MEK | 22556409 |
N87 | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
NIH 3T3 | 2 μM | Function Assay | 18 h | inhibits mTORC2 phosphorylation of Akt on Ser473 and mTORC1 phosphorylation of 4E-BP1 on Thr37/46 | 21876130 |
OCI-AML3 | 2.5 μM | Apoptosis Assay | 72 h | induces apoptosis | 22826565 |
p210 BCR-Abl | 100/200/400 nM | Function Assay | 18 h | inhibits mTORC1-dependent S6 S235/236 phosphorylation | 22566604 |
p210 BCR-Abl | 400nM | Growth Inhibition Assay | 24/48 h | synergize with 17-AAG to suppress cell proliferation | 22566604 |
PC12 | 40 nM | Function Assay | - | induces lysosomal biogenesis and alleviated α-SYN accumulation | 26001614 |
Rh30 | 1 μM | Function Assay | 2 h | inhibits both mTORC1-mediated phosphorylation of S6K1 and mTORC2-mediated phosphorylation of Akt | 25762619 |
Rh30 | 1 μM | Function Assay | 2 h | suppresses the basal or IGF-1-stimulated cell adhesion | 25762619 |
Saos-2 | 50-1000 nM | Function Assay | 0.5 h | dose dependently (50–1000 nM) inhibits phosphorylation of Akt | 24840134 |
Saos-2 | 100 nM | Function Assay | 0.5 h | prevents osteosarcoma cell migration | 24840134 |
Saos-2 | 100 nM | Apoptosis Assay | 36 h | promotes apoptosis | 24840134 |
SGC7901 | 0-1000 nM | Cell Viability Assay | 24/48 h | decreases cell viability in time and dose dependent manner | 25035961 |
SK-CO-1 | - | Growth Inhibition Assay | - | IC50=4 μM | 23542178 |
SK-CO-1 | - | Growth Inhibition Assay | - | IC50=2.1 μM | 22270257 |
SW1116 | - | Growth Inhibition Assay | - | IC50=0.84 μM | 23542178 |
SW48 | - | Growth Inhibition Assay | - | IC50=0.09 μM | 23542178 |
SW-48 | - | Growth Inhibition Assay | - | IC50=0.1 μM | 22270257 |
SW480 | - | Growth Inhibition Assay | - | IC50=4.6 μM | 23542178 |
SW480 | 10/100/1000 nM | Function Assay | 6 h | inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein | 22401294 |
SW620 | - | Growth Inhibition Assay | - | IC50=7.8 μM | 23542178 |
SW620 | - | Growth Inhibition Assay | - | IC50=11 μM | 22270257 |
SW620 | 0.5/2 μM | Function Assay | 4 h | blocks all three mTOR outputs | 21876130 |
SW620-R | - | Growth Inhibition Assay | - | IC50=1.3 μM | 22270257 |
Sw948 | 0-1000 nM | Cell Viability Assay | 24 h | inhibits the growth in a dose-dependent manner | 23991179 |
Sw948 | 1 μM | Function Assay | 0-24 h | abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 | 23991179 |
T24 | - | Growth Inhibition Assay | - | IC50=1.37 ± 0.4 μM | 24054871 |
T47D | 50/200/500 nM | Function Assay | 30 min | dose-dependently (50–500 nM) suppresses phosphorylation of Akt | 22476852 |
THP-1 | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
TMD7 | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
TMD8 | 0.25/0.5/1 μM | Growth Inhibition Assay | - | inhibits cell growth dose dependently | 23482748 |
U2OS | 50-1000 nM | Function Assay | 0.5 h | dose dependently (50–1000 nM) inhibits phosphorylation of Akt | 24840134 |
U2OS | 100 nM | Apoptosis Assay | 36 h | promotes apoptosis | 24840134 |
U87 | 25 nM | Growth Inhibition Assay | 24 h | increases DUSP10 knocked-down induced cell inhibition | 25568665 |
U87vIII | 0.04-2.5 μM | Function Assay | 24 h | inhibits mTORC1 and mTORC2 activities | 26134617 |
U87vIII | 2.5/5 μM | Function Assay | 12 h | inhibits gap closing in a dose-dependent manner | 26134617 |
UM-UC-3 | - | Growth Inhibition Assay | - | IC50=0.63 ±0.1 μM | 24054871 |
靶点 | Description | IC50 |
---|---|---|
Bromodomain 4 | Kd:1.7μM | |
mTOR | IC50:8nM | |
p110δ | IC50:100nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网